S. M. Winters

Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).

G. Lip, R. de Caterina, A. Goette, 2018, The American journal of cardiology.

Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).

G. Lip, A. Goette, N. Al-Saady, 2017, The American journal of cardiology.

Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.

G. Raskob, W. Ageno, H. Büller, 2016, The Lancet. Haematology.

Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial

G. Lip, A. Goette, K. Huber, 2020, Clinical Research in Cardiology.

Spontaneous conversion in patients with non‐valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE‐AF) trial

G. Lip, H. Heidbuchel, R. de Caterina, 2019, American heart journal.

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis

G. Lip, H. Heidbuchel, R. de Caterina, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study

G. Raskob, W. Ageno, H. Büller, 2017, Thrombosis and Haemostasis.

Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.

G. Raskob, W. Ageno, H. Büller, 2018, Thrombosis research.

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF).

G. Lip, A. Goette, G. Boriani, 2019, The American journal of cardiology.